quinoxalines has been researched along with s 1033 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dörken, B; Grille, P; Kaeda, J; le Coutre, P; Manley, PW; Marque, F; Oberender, C; Radimerski, T; Ringel, F; Schwarz, M | 1 |
1 other study(ies) available for quinoxalines and s 1033
Article | Year |
---|---|
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Janus Kinase 2; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Myeloproliferative Disorders; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quinoxalines; STAT5 Transcription Factor; Tumor Suppressor Proteins | 2014 |